BMX as a Molecular Target for Radiosensitizing Agents

Summary

Provided are methods for modulating the proliferation of cells and tissues. In some embodiments, the methods include administering to a subject an effective amount of a modulator of a biological activity of a bone marrow X kinase (Bmx) gene product. Also provided are methods for increasing the radiosensitivity of a target cell or tissue, methods for suppressing tumor growth, methods for inhibiting tumor blood vessel growth, and compositions that include modulators of a biological activity of a bone marrow X kinase (Bmx) gene product.

Intellectual Property Status

U.S. Patent # 8,129,356 was issued March 6, 2012.


Licensing Contact

Taylor Jordan

615.936.7505
Tech ID:
VU0817
Therapeutics